Ophthalmic Sutures Market (By Type: Natural, Synthetic; By Absorption Capacity: Absorbable, Non-absorbable; By Application: Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy Surgery, Iridectomy Surgery, Oculoplastic Surgery, Others; By End-use: Hospitals, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ophthalmic Sutures Market 

5.1. COVID-19 Landscape: Ophthalmic Sutures Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ophthalmic Sutures Market, By Type

8.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by Type, 2024-2033

8.1.1. Natural

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Synthetic

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Ophthalmic Sutures Market, By Absorption Capacity

9.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by Absorption Capacity, 2024-2033

9.1.1. Absorbable

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Non-absorbable

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Ophthalmic Sutures Market, By Application 

10.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by Application, 2024-2033

10.1.1. Corneal Transplantation Surgery

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Cataract Surgery

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Vitrectomy Surgery

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Iridectomy Surgery

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Oculoplastic Surgery

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Ophthalmic Sutures Market, By End-use 

11.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by End-use, 2024-2033

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Ambulatory Surgical Centers

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Ophthalmic Sutures Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

Chapter 13. Company Profiles

13.1. Accutome Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Asset Medical Sarl

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Alcon Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Aurolab

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. FCI Ophthalmic Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Medtronic Plc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Rumex International Co.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Surgical Specialties Corp

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Teleflex Incorporated

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Unilever

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample